Statistics for Neurones (id:10702 NRO)
Valuation metrics
Market cap
1.12B
Enterprise value
924.97M
Trailing P/E (ttm)
22.71
Forward P/E
20.55
PEG ratio
20.55
Price/Sales (ttm)
1.45
Price/Book (mrq)
3.14
Enterprise Value/Revenue
1.19
Enterprise Value/EBITDA
11.25
Overview
Shares outstanding
24.27M
Float
8.80M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
5.68K
Average volume (90 days)
Price summary
52-Week low
39.45
52-Week high
48.15
52-Week change
3.00%
Beta
3.00
50-Day moving average
45.27
200-Day moving average
44.58
Dividends and splits
Forward annual dividend rate
4.80
Forward annual dividend yield
3.00
Trailing annual dividend rate
1.20%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
3.00
Payout ratio
3.00
Dividend date
Ex-dividend date
June 12, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
6.26%
Operating margin
9.19%
Operational effectiveness
Return on assets
7.06%
Return on equity
14.87%
Income statement
Revenue (ttm)
31.94
Revenue per share (ttm)
31.94
Quarterly revenue growth (yoy)
5.00
Gross profit (ttm)
457.51M
EBITDA
97.37M
Net income to common (ttm)
48.49M
Diluted EPS (ttm)
1.99
Quarterly earnings growth (yoy)
-3.60%
Balance sheet
Total cash (mrq)
268.12M
Total cash per share (mrq)
11.04
Total debt (mrq)
46.73M
Total Debt/Equity (mrq)
11.71
Current ratio (mrq)
224.50%
Book value per share (mrq)
14.41
Cash flow
Cash flow statement
62.18M
Levered free cash flow (LFCF)
42.64M